Faculty profile

Professor EmeritusPathology & Molecular MedicineMcMaster University

Research

Research areas, by share of publications

Research areas are derived from OpenAlex topics of their publications.

114 publications.

01

CHEMOTHERAPY OF CANINE LYMPHOMA WITH HISTOPATHOLOGICAL CORRELATION - DOXORUBICIN ALONE COMPARED TO COP AS 1ST TREATMENT REGIMEN

CARTER RF, HARRIS CK, WITHROW SJ, VALLI VEO, SUSANECK SJ

Journal of the American Animal Hospital Association88 citationsFirst author
02

Translation of Knowledge to Practice—Improving Awareness in NSCLC Molecular Testing

Zer A, Cutz JC, Sekhon H, Hwang DM, Sit C, Maganti M, Sung M, Binnie M, Brade A, Chung TB

Journal of Thoracic Oncology201815 citations
03

Improving molecular testing and personalized medicine in non-small-cell lung cancer in Ontario.

Lim C, Sekhon HS, Cutz JC, Hwang DM, Kamel-Reid S, Carter RF, Santos GDC, Waddell T, Binnie M, Patel M

Current Oncology201739 citationsOpen Access
04

Gender and BCR‐ABL transcript type are correlated with molecular response to imatinib treatment in patients with chronic myeloid leukemia

Lin H-X, Sjaarda J, Dyck J, Stringer R, Hillis C, Harvey M, Carter R, Ainsworth P, Leber B, Pare G

European Journal of Haematology201641 citations
05

MG-143 Age is significantly associated with the bone marrow engraftment in patients with allogeneic stem cell transplantation

Lin H, Stringer R, Dyck J, Sjaarda J, Li W, Freitag AP, Pare G, Carter RF, Sadikovic B

Journal of Medical Genetics2015
06

Canadian Anaplastic Lymphoma Kinase Study: A Model for Multicenter Standardization and Optimization of ALK Testing in Lung Cancer

Cutz J-C, Craddock KJ, Torlakovic E, Brandao G, Carter RF, Bigras G, Deschenes J, Izevbaye I, Xu Z, Greer W

Journal of Thoracic Oncology201479 citations
07

A targeted intervention to improve awareness to molecular testing in NSCLC.

Zer A, Cutz J-C, Sekhon HS, Hwang DM, Sit C, Binnie M, Brade AM, Chung T, Kamel-Reid S, Narinder P

Journal of Clinical Oncology20141 citations
08

The effects of irrigation on outcomes in cases of perforated appendicitis in children

Hartwich JE, Carter RF, Wolfe L, Goretsky M, Heath K, St. Peter SD, Lanning DA

Journal of Surgical Research201355 citations
09

Canadian ALK (CALK): A pan-Canadian multicenter study to optimize and standardize ALK immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) for ALK gene rearrangements.

Tsao MS, Craddock K, Brandao G, Xu Z, Greer W, Yatabe Y, Ionescu D, Jung S, Carter RF, Karsan A

Journal of Clinical Oncology20132 citations
10

Canadian ALK (CALK): A pan-Canadian multicenter study to optimize and standardize ALK immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) for ALK gene rearrangements

Tsao MS, Craddock K, Brandao G, Xu Z, Greer W, Yatabe Y, Ionescu D, Jung S, Carter RF, Karsan A

Journal of Clinical Oncology2013
Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for
Subject: Prospective PhD student: Lung Cancer Diagnosis and Treatment Dear Professor Carter, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "CHEMOTHERAPY OF CANINE LYMPHOMA WITH HISTOPATHOLOGICAL CORRELATION - DOXORUBICIN ALONE COMPARED TO COP AS 1ST TREATMENT REGIMEN", and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]
Open in email
Something wrong or missing on this profile? Suggest a correction